Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 104, Issue 15, Pages 6371-6376Publisher
NATL ACAD SCIENCES
DOI: 10.1073/pnas.0700548104
Keywords
inflammation; Toll-like receptor; sepsis; innate immunity
Categories
Funding
- NCI NIH HHS [CA69381, P01 CA069381, CA078419, R01 CA078419] Funding Source: Medline
- NIAID NIH HHS [AI070859] Funding Source: Medline
Ask authors/readers for more resources
Ubc13 is a ubiquitin-conjugating enzyme responsible for noncanonical ubiquitination of TNF receptor-associated factor (TRAF)family adapter proteins involved in Toll-like receptor and TNF-family cytokine receptor signaling, which are regulators of innate immunity. Gene ablation was used to study the function of Ubc13 in mice. Whereas homozygous ubc13 gene disruption resulted in embryonic lethality, heterozygous ubc13(+/-) mice appeared normal, without alterations in immune cell populations. Haploinsufficient ubc13(+/-) mice were resistantto lipopolysaccharicle-incluced lethality, and demonstrated reduced in vivo ubiquitination of TRAF6. Macrophages and splenocytes isolated from ubc1(3+/-) mice exhibited reduced lipopolysaccharicle-inclucible cytokine secretion and impaired activation of TRAF-dependent signal transcluction pathways (NIF-kappa B, JNK, and p38 MAPK). These findings document a critical role for Ubc13 in inflammatory responses and suggestthat agents reducing Ubc13 activity could have therapeutic utility.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available